Sally Mahmoud

7PUBLICATIONS
17CO-AUTHORS
Nanotoxicology, health and safetyInnate immunitySensor technology (incl. chemical aspects)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2024
Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.

Suad Hannawi, Linda Saf Eldin, Alaa Abuquta

|Jul 08, 2023
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.

Suad Hannawi, Linda Saf Eldin, Alaa Abuquta

|Jan 03, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.

Nawal Al Kaabi, Yun Kai Yang, Yu Liang

|Oct 24, 2022
Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine.

Sally Mahmoud, Subhashini Ganesan, Narjes Saheb Sharif-Askari

|Jun 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.

Nawal Al Kaabi, Yun Kai Yang, Li Fang Du

|Jun 06, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.

Nawal Al Kaabi, Yun Kai Yang, Jing Zhang

Pageof 2